Beta Bionics hit net sales of $44.7m in the first nine months of 2024, marking an increase from $3.6m in 2023. Beta Bionics’ ...

The company previously announced unaudited preliminary fourth quarter net sales between $45.1 million to $46.6 million and full year 2024 preliminary unaudited net sales projected to range ...

About This EventBeta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the design, development of advanced diabetes management solutions, visits the Nasdaq MarketSite in Times Square.In honor of ...

Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...

Stock futures edged higher Thursday night as investors analyzed earnings reports from Apple and other well-known companies ...

Wall Street's major averages notice limited moves on Thursday, as the Q4 GDP growth came in weaker than expected, while investors digested the tech earnings.

The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...

Franklin Templeton Canada today announced the listing of Franklin U.S. Mid Cap Multifactor Index ETF (FMID) for Canadians looking to diversify beyond U.S. large cap equities. With an emphasis on high ...

Merck & Co. Inc. 0.85% $248.61B ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stock futures were higher Thursday, as investors digested a round of big tech earnings results. Follow live market updates. An American Airlines regional jet collided midair with a Black Hawk military ...